Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 10 studies | 48% ± 17% | |
neuron | 8 studies | 43% ± 18% | |
GABAergic neuron | 8 studies | 36% ± 19% | |
oligodendrocyte precursor cell | 6 studies | 28% ± 11% | |
amacrine cell | 5 studies | 42% ± 18% | |
interneuron | 5 studies | 36% ± 14% | |
retina horizontal cell | 4 studies | 28% ± 12% | |
retinal bipolar neuron | 3 studies | 34% ± 11% | |
GABAergic amacrine cell | 3 studies | 30% ± 10% | |
glycinergic amacrine cell | 3 studies | 27% ± 9% | |
retinal ganglion cell | 3 studies | 41% ± 24% | |
astrocyte | 3 studies | 27% ± 12% | |
Mueller cell | 3 studies | 21% ± 6% | |
rod bipolar cell | 3 studies | 30% ± 9% | |
granule cell | 3 studies | 30% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 98% | 17698.93 | 2597 / 2642 | 100% | 233.84 | 703 / 705 |
adrenal gland | 11% | 274.84 | 29 / 258 | 66% | 142.26 | 151 / 230 |
thymus | 10% | 158.47 | 64 / 653 | 34% | 9.09 | 207 / 605 |
pancreas | 0% | 5.70 | 1 / 328 | 28% | 8.91 | 50 / 178 |
lung | 0% | 4.78 | 2 / 578 | 23% | 14.09 | 265 / 1155 |
uterus | 1% | 7.19 | 1 / 170 | 16% | 6.73 | 72 / 459 |
prostate | 1% | 31.02 | 3 / 245 | 14% | 1.78 | 70 / 502 |
skin | 2% | 32.78 | 37 / 1809 | 11% | 3.91 | 52 / 472 |
ovary | 0% | 0 | 0 / 180 | 10% | 2.41 | 43 / 430 |
intestine | 7% | 104.70 | 65 / 966 | 2% | 0.31 | 11 / 527 |
breast | 1% | 9.82 | 3 / 459 | 7% | 0.74 | 74 / 1118 |
kidney | 3% | 60.26 | 3 / 89 | 3% | 0.73 | 29 / 901 |
eye | 0% | 0 | 0 / 0 | 6% | 1.59 | 5 / 80 |
esophagus | 3% | 58.16 | 47 / 1445 | 3% | 0.25 | 5 / 183 |
heart | 5% | 104.82 | 44 / 861 | 0% | 0 | 0 / 0 |
stomach | 1% | 7.07 | 2 / 359 | 4% | 0.47 | 12 / 286 |
bladder | 0% | 0 | 0 / 21 | 4% | 3.99 | 18 / 504 |
blood vessel | 3% | 39.20 | 35 / 1335 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 1% | 0.14 | 4 / 406 |
adipose | 0% | 4.60 | 4 / 1204 | 0% | 0 | 0 / 0 |
muscle | 0% | 4.35 | 2 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001658 | Biological process | branching involved in ureteric bud morphogenesis |
GO_0000139 | Cellular component | Golgi membrane |
GO_0016020 | Cellular component | membrane |
Gene name | TMEM59L |
Protein name | Transmembrane protein 59 like Transmembrane protein 59-like (Brain-specific membrane-anchored protein) |
Synonyms | C19orf4 BSMAP |
Description | FUNCTION: Modulates the O-glycosylation and complex N-glycosylation steps occurring during the Golgi maturation of APP. Inhibits APP transport to the cell surface and further shedding. . |
Accessions | Q9UK28 ENST00000594709.1 ENST00000262817.8 ENST00000600490.5 M0R134 |